add items to your
binder to email or
print all at once
Items In Binder
Site Lawyers
Johnson & Johnson's $4.325 Billion Acquisition of Abbott Medical Optics

On September 16, 2016, Johnson & Johnson announced a definitive agreement to acquire Abbott Medical Optics, a wholly owned subsidiary of Abbott Laboratories, for $4.325 billion in cash. The acquisition will include ophthalmic products in three business segments: cataract surgery, laser refractive surgery and consumer eye health. Cravath is representing Johnson & Johnson in connection with the transaction.

The Cravath team is led by partners Robert I. Townsend III and Damien R. Zoubek and includes associates Peter J. Atlee and Justin B. Stein on M&A matters; partner J. Leonard Teti II and associate Tara L. Rhoades on tax matters; partner Jonathan J. Katz and associates Matthew J. Bobby and Daniel P. Herrmann on executive compensation and benefits matters; partner David J. Kappos and associate Jason M. Sandler on intellectual property matters; and partner Matthew Morreale on environmental matters.